BERTAGNIN, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 773
EU - Europa 163
AS - Asia 160
SA - Sud America 4
AF - Africa 3
Totale 1.103
Nazione #
US - Stati Uniti d'America 772
CN - Cina 101
SG - Singapore 51
IT - Italia 46
DE - Germania 28
FR - Francia 20
RU - Federazione Russa 16
FI - Finlandia 14
IE - Irlanda 14
GB - Regno Unito 6
SE - Svezia 6
ES - Italia 4
UA - Ucraina 4
GH - Ghana 3
IN - India 3
BR - Brasile 2
JP - Giappone 2
PT - Portogallo 2
BO - Bolivia 1
CA - Canada 1
CL - Cile 1
DK - Danimarca 1
LA - Repubblica Popolare Democratica del Laos 1
MY - Malesia 1
NL - Olanda 1
RO - Romania 1
TH - Thailandia 1
Totale 1.103
Città #
Fairfield 115
Ashburn 82
Chandler 79
Woodbridge 52
Cambridge 46
Seattle 46
Singapore 43
Houston 40
Ann Arbor 30
Santa Clara 29
Wilmington 26
Columbus 24
Beijing 22
Boardman 22
San Diego 20
Dublin 14
Helsinki 14
Frankfurt am Main 12
Medford 11
Padova 11
Princeton 11
Roxbury 9
Des Moines 8
Berlin 7
Guangzhou 7
Shanghai 6
Washington 6
Milan 4
Accra 3
Falls Church 3
Kharkiv 3
Madrid 3
Nanjing 3
Palermo 3
Pune 3
Rome 3
Shenzhen 3
Turin 3
Americana 2
Borås 2
Camponogara 2
Dallas 2
Dearborn 2
Fuzhou 2
Hefei 2
London 2
Los Angeles 2
New York 2
Agordo 1
Buffalo 1
Cartagena 1
Chicago 1
Cochabamba 1
Copenhagen 1
Fossò 1
Hangzhou 1
Hanover 1
Islington 1
Jiaxing 1
Kuala Lumpur 1
Kunming 1
Kyiv 1
Moscow 1
Nanchang 1
Newark 1
Norwalk 1
Ogden 1
San Jose 1
Saskatoon 1
Shenyang 1
Shijiazhuang 1
Strasbourg 1
Taizhou 1
Vientiane 1
Wuhan 1
Wuxi 1
Zhengzhou 1
Totale 875
Nome #
Potent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target the PA-PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance 139
1,2,4-Triazolo[1,5-a]pyrimidines: Efficient one-step synthesis and functionalization as influenza polymerase PA-PB1 interaction disruptors 120
Optimization of N-Substituted Oseltamivir Derivatives as Potent Inhibitors of Group-1 and -2 Influenza A Neuraminidases, Including a Drug-Resistant Variant 117
A quantitative LumiFluo assay to test inhibitory compounds blocking p53 degradation induced by human papillomavirus oncoprotein E6 in living cells 116
Structure-Based Optimization of N-Substituted Oseltamivir Derivatives as Potent Anti-Influenza A Virus Agents with Significantly Improved Potency against Oseltamivir-Resistant N1-H274Y Variant 115
A novel small-molecule inhibitor of the human papillomavirus E6-p53 interaction that reactivates p53 function and blocks cancer cells growth 93
Synthesis and characterization of 1,2,4-triazolo[1,5-a]pyrimidine-2-carboxamide-based compounds targeting the PA-PB1 interface of influenza A virus polymerase 68
Discovery of highly potent and selective influenza virus neuraminidase inhibitors targeting 150-cavity 67
The dimeric form of hpv16 e6 is crucial to drive yap/taz upregulation through the targeting of hscrib 64
A small molecule targeting the interaction between human papillomavirus E7 oncoprotein and cellular phosphatase PTPN14 exerts antitumoral activity in cervical cancer cells 44
Identification of C5-NH2 Modified Oseltamivir Derivatives as Novel Influenza Neuraminidase Inhibitors with Highly Improved Antiviral Activities and Favorable Druggability 41
Targeted disruption of e6/p53 binding exerts broad activity and synergism with paclitaxel and topotecan against hpv-transformed cancer cells 38
Discovery of Novel Boron-Containing N-Substituted Oseltamivir Derivatives as Anti-Influenza A Virus Agents for Overcoming N1-H274Y Oseltamivir-Resistant 30
Iterative Optimization and Structure-Activity Relationship Studies of Oseltamivir Amino Derivatives as Potent and Selective Neuraminidase Inhibitors via Targeting 150-Cavity 26
Discovery of N-substituted oseltamivir derivatives as novel neuraminidase inhibitors with improved drug resistance profiles and favorable drug-like properties 21
Switching the three-component Biginelli-like reaction conditions for the regioselective synthesis of new 2-amino[1,2,4]triazolo[1,5-a]pyrimidines 10
A novel N-heterocycles substituted oseltamivir derivatives as potent inhibitors of influenza virus neuraminidase: discovery, synthesis and biological evaluation 9
Optimization of potent, broad-spectrum, and specific anti-influenza compounds targeting RNA polymerase PA-PB1 heterodimerization 9
Exploring a New Generation of Pyrimidine and Pyridine Derivatives as Anti-Influenza Agents Targeting the Polymerase PA–PB1 Subunits Interaction 7
Elaborate Structural Modifications Yielding Novel Boron-Containing N-Substituted Oseltamivir Derivatives as Potent Neuraminidase Inhibitors with Significantly Improved Broad-Spectrum Antiresistance Profiles 2
Totale 1.136
Categoria #
all - tutte 5.859
article - articoli 5.859
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.718


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020113 0 0 0 0 0 14 21 23 23 14 13 5
2020/2021136 4 8 2 7 2 4 1 9 28 5 33 33
2021/2022201 4 9 20 26 17 17 11 21 3 12 24 37
2022/2023198 28 17 8 16 29 39 0 12 19 12 11 7
2023/2024202 2 16 41 11 26 21 29 21 2 11 7 15
2024/2025194 1 31 43 26 56 37 0 0 0 0 0 0
Totale 1.136